MG217® Eczema Cream Lawsuit | Recall Lawyer, Attorney

Pharmacal recalled MG217® Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream due to a risk of infections with Staphylococcus aureus. If you had a skin infection, blood infection, or sepsis, it was not your fault.

What You Can Do & How We Can Help

The Schmidt Firm, PLLC is currently accepting MG217 Eczema Cream injury cases in all 50 states. If you got a staph infection or other serious illness from MG217 Eczema Cream that was recalled at H-E-B, Amazon, and other stores for Staphylococcus aureus contamination, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Product Recall Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Quick Facts

Recalled by: Pharmacal (Jackson, WI)
Product: MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube
Recall date: May 8, 2026 (FDA published May 12, 2026)
Lot affected: Lot 1024088, expiration November 2026
Product code: 5106 | UPC: 012277051067
Hazard: Contamination with Staphylococcus aureus, which can cause skin infections, bloodstream infections, endocarditis, and sepsis
Distribution: Nationwide — wholesale, retail (including H-E-B grocery), and Amazon
What to do: Stop using and discard the product
Official source: FDA recall notice

MG217 Eczema Cream Recalled for Staphylococcus aureus Contamination

In May 2026, Pharmacal recalled one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream after the product was found to be contaminated with Staphylococcus aureus. No illnesses have been reported to date.

What Is the Problem?

The recalled MG217 eczema cream may be contaminated with Staphylococcus aureus, a bacteria that lives harmlessly on skin in many healthy people but can cause severe infection when it enters the body through broken skin. Because eczema cream is applied directly to broken, cracked, and inflamed skin, the contamination may create a direct route for the bacteria to enter the body.

Pharmacal described the risk in its FDA-published recall notice as follows:

“Use of the product could result in a range of infections from localized to severe or life-threatening adverse events. Patients with weakened immune systems or compromised skin — such as those with wounds, burns, or skin disorders — are at increased risk for serious infections, including skin and skin structure infections, infective endocarditis (infection of the heart valves), bone and joint infections, bloodstream infections, and life-threatening conditions like sepsis and septic shock.”

To date, Pharmacal has not received any reports of adverse events related to this recall.

What Are the Dangers of Staphylococcus aureus?

Staphylococcus aureus (commonly called “staph”) is a bacteria that can cause a wide spectrum of infections. According to the CDC, staph bacteria are a leading cause of healthcare-associated infections and can cause serious harm when they enter the body through cuts, wounds, or compromised skin.

When applied directly to eczema-damaged skin, contaminated cream can introduce staph bacteria into the deeper layers of skin and, from there, into the bloodstream. Once invasive, staph can travel to virtually any organ system.

Possible Staphylococcus aureus infections include:

Skin and soft tissue infections — boils, abscesses, cellulitis, impetigo, and folliculitis
Bloodstream infections (bacteremia) — bacteria circulating in the blood
Sepsis and septic shock — a body-wide inflammatory response that can be fatal
Infective endocarditis — infection of the heart valves
Pneumonia — infection of the lungs
Osteomyelitis — bone infection
Septic arthritis — joint infection
Toxic shock syndrome — a rapid, life-threatening reaction to staph toxins
Food poisoning — when staph toxins are ingested

Some staph strains, such as methicillin-resistant Staphylococcus aureus (MRSA), are resistant to common antibiotics like methicillin, penicillin, amoxicillin, and oxacillin. MRSA infections are much harder to treat and are linked to longer hospital stays, higher treatment costs, and increased mortality.

Who Is at Highest Risk?

Pharmacal identified two groups as being at the greatest risk of serious harm from the contaminated product:

People with weakened immune systems
People with compromised skin — including wounds, burns, and skin disorders

Eczema is characterized by inflamed, cracked, and broken skin. This is the precise condition that the recalled product was sold to treat. That overlap is what makes this recall due to bacterial contamination especially concerning.

How To Identify Recalled MG217 Eczema Cream

The recall is limited to a single lot of the product:

Product: MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream
Size: 6oz tube
Lot number: 1024088 (printed on the crimped end of the tube)
Expiration date: November 2026
Product code: 5106
UPC: 012277051067

The product was distributed nationwide through wholesale distributors, retail stores (including H-E-B grocery), and internet distributors including Amazon.

What Should I Do?

Pharmacal has advised consumers who have the recalled product to stop using it and discard it. The company is notifying its distributors by email and arranging the return of all recalled products.

Consumers with questions about the recall can contact Pharmacal at 800-558-6614 or by email at aimho@pharmacalway.com, Monday through Friday from 8 a.m. to 5 p.m. central time. The FDA recommends that anyone who has experienced problems they believe may be related to using this product contact their physician or healthcare provider.

For full recall details, see the FDA recall notice.

Do I Have an MG217 Eczema Cream Lawsuit?

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.